|
Jul 27
|
Lantheus Holdings Expands Alzheimer’s Diagnostics Despite Recent Stock Dip
|
|
Jul 23
|
Lantheus to Host Second Quarter 2025 Earnings Conference Call and Webcast on August 6, 2025, at 8:00 a.m. Eastern Time
|
|
Jul 22
|
Lantheus Completes Acquisition of Life Molecular Imaging and Appoints Dr. Ludger Dinkelborg as Head of R&D
|
|
Jul 18
|
Lantheus (LNTH): Buy, Sell, or Hold Post Q1 Earnings?
|
|
Jul 2
|
Lantheus’s Q1 Earnings Call: Our Top 5 Analyst Questions
|
|
Jun 30
|
Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT
|
|
Jun 28
|
Lantheus Joins FIBRE Consortium with Pfizer, Lumina to Revolutionize Fibrotic Disease Treatment
|
|
May 9
|
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures
|
|
May 9
|
Lantheus price target lowered to $120 from $134 at JonesResearch
|
|
May 9
|
Lantheus Holdings, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
|
|
May 8
|
LNTH: Sale of SPECT Tilts Growth to Novel Radiopharmaceuticals
|
|
May 8
|
Lantheus Holdings First Quarter 2025 Earnings: Misses Expectations
|
|
May 8
|
Why Lantheus Holdings, Inc. (LNTH) Nosedived on Wednesday
|
|
May 8
|
Lantheus Holdings Inc (LNTH) Q1 2025 Earnings Call Highlights: Strategic Moves Amidst Mixed ...
|
|
May 8
|
Q1 2025 Lantheus Holdings Inc Earnings Call
|
|
May 7
|
Why Lantheus (LNTH) Shares Are Getting Obliterated Today
|
|
May 7
|
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops
|
|
May 7
|
Lantheus Holdings: Q1 Earnings Snapshot
|
|
May 7
|
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
|
|
May 6
|
Lantheus Announces Sale of SPECT Business to SHINE Technologies
|